In this video

Share

Amarin CEO on Vascepa heart drug trial

John Thero, Amarin president and CEO, discusses Amarin's successful clinical trial for its fish oil-derived heart drug, Vascepa. CNBC's Meg Tirrell also weighs in.
04:15
Mon, Sep 24 20182:42 PM EDT